These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 30181304)

  • 1. Correction: Cofilin Drives Cell-Invasive and Metastatic Responses to TGF-β in Prostate Cancer.
    Cancer Res; 2018 Sep; 78(17):5180. PubMed ID: 30181304
    [No Abstract]   [Full Text] [Related]  

  • 2. Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells.
    Zhu B; Fukada K; Zhu H; Kyprianou N
    Cancer Res; 2006 Sep; 66(17):8640-7. PubMed ID: 16951178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
    Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
    Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67.
    Richardsen E; Uglehus RD; Due J; Busch C; Busund LT
    Cancer Epidemiol; 2010 Jun; 34(3):316-22. PubMed ID: 20409773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells.
    Virtanen SS; Ishizu T; Sandholm JA; Löyttyniemi E; Väänänen HK; Tuomela JM; Härkönen PL
    Oncotarget; 2018 Aug; 9(66):32593-32608. PubMed ID: 30220968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
    Sehgal I; Baley PA; Thompson TC
    Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
    Shariat SF; Shalev M; Menesses-Diaz A; Kim IY; Kattan MW; Wheeler TM; Slawin KM
    J Clin Oncol; 2001 Jun; 19(11):2856-64. PubMed ID: 11387358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.
    Steiner MS; Barrack ER
    Mol Endocrinol; 1992 Jan; 6(1):15-25. PubMed ID: 1738367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.
    Qin T; Barron L; Xia L; Huang H; Villarreal MM; Zwaagstra J; Collins C; Yang J; Zwieb C; Kodali R; Hinck CS; Kim SK; Reddick RL; Shu C; O'Connor-McCourt MD; Hinck AP; Sun LZ
    Oncotarget; 2016 Dec; 7(52):86087-86102. PubMed ID: 27863384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
    Tu H; Jacobs SC; Borkowski A; Kyprianou N
    Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced invasive and metastatic potential induced by transforming growth factor-beta1 might be correlated with glutathione-S-transferase-pi, cofilin and heat shock protein 27 in SGC-7901 gastric cancer cells.
    Wang K; Li J; Zhen C; Zhou J; Xiao D; Liu J; Liu Y; Jiang H; Chen C; Wen J
    Acta Biochim Biophys Sin (Shanghai); 2007 Jul; 39(7):520-6. PubMed ID: 17622471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta.
    Wilding G
    Cancer Surv; 1991; 11():147-63. PubMed ID: 1841749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of TGF-beta/Smads pathway in human prostate cancer cell lines and its significance].
    Wu KJ; Zhu GF; Zhang D; Zeng J; Wang XY; Xue Y; Zhang LL; He DL
    Zhonghua Nan Ke Xue; 2009 Oct; 15(10):920-4. PubMed ID: 20112742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.
    Chen XH; Liu ZC; Zhang G; Wei W; Wang XX; Wang H; Ke HP; Zhang F; Wang HS; Cai SH; Du J
    Mol Immunol; 2015 May; 65(1):34-42. PubMed ID: 25618241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
    Baruah MM; Khandwekar AP; Sharma N
    Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
    Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
    Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.